Krishnamurthi K, Zheng W, Verbalis A D, Sandberg K
Department of Medicine, Georgetown University Medical Center, Washington, DC 20007-2145, USA.
Biochem Biophys Res Commun. 1998 Apr 28;245(3):865-70. doi: 10.1006/bbrc.1998.8538.
RNA binding proteins (BPs) have been identified which bind within a -271 to -174 nt domain in the 5' leader sequence (5'LS) of the rat type 1 angiotensin (AT1) receptor mRNA and which encompass RNA cis elements upstream of -239. A 100 kDa RNA-protein complex is observed by UV-crosslinking in several tissues including brain, lung, and spleen. 5'LS RNA transcripts of the 1a and 1b AT receptor subtypes are strong competitors of 5'LS-protein complex formation. In contrast, antisense 5'LS AT1a transcripts, plasmid transcripts, poly U and poly A RNAs, or 5'LS AT1a cDNA are poor competitors. Deoxycorticosterone acetate (DOCA) decreased 5'LS-BP activities in the forebrain and hypothalamus under conditions known to significantly increase AT1 receptor expression. DOCA had no effect on 5'LS-BP activities in the pituitary which correlates with its lack of effect on pituitary AT1 receptor expression. These results indicate that DOCA differentially regulates 5'LS-BP activities in a tissue-specific manner and suggest that physiologically mediated changes in AT1 receptor expression are mediated by alterations in 5'LS-BP activities, which represents a previously unrecognized level of regulation for the renin angiotensin system.
已鉴定出RNA结合蛋白(BPs),它们结合在大鼠1型血管紧张素(AT1)受体mRNA的5'前导序列(5'LS)中-271至-174 nt的结构域内,且包含-239上游的RNA顺式元件。通过紫外线交联在包括脑、肺和脾在内的多种组织中观察到一种100 kDa的RNA-蛋白质复合物。1a和1b AT受体亚型的5'LS RNA转录本是5'LS-蛋白质复合物形成的强竞争者。相比之下,反义5'LS AT1a转录本、质粒转录本、聚U和聚A RNA或5'LS AT1a cDNA是较弱的竞争者。在已知能显著增加AT1受体表达的条件下,醋酸脱氧皮质酮(DOCA)降低了前脑和下丘脑中5'LS-BP的活性。DOCA对垂体中5'LS-BP的活性没有影响,这与其对垂体AT1受体表达缺乏影响相关。这些结果表明,DOCA以组织特异性方式差异调节5'LS-BP的活性,并提示AT1受体表达的生理介导变化是由5'LS-BP活性的改变介导的,这代表了肾素血管紧张素系统先前未被认识的调节水平。